CANARY FUND
Mission Statement
Canary Foundation is the world’s first nonprofit dedicated solely to cancer early detection. We are developing simple tests that identify and isolate cancer at its earliest, most curable stage. Our programs are positioned to prove a cancer early detection platform beginning with multi-institutional research in ovarian, prostate, lung, breast, and pancreatic cancers. We also partner with Stanford University in the Canary Center at Stanford for cancer early detection. 90% of people survive cancer when it is detected early. 90% of people don’t survive when it is detected late. Cancer is almost always detected late. Early Detection Saves Lives
Financial Overview — FY 2025
Compared with Peers
FY 2025| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
92.0% | 91.3% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.7% | 8.2% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.2% | 2.6% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.6 mo | 65.7 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
28.9% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.1% | 90.4% |
P10P90
|
Bottom quarter |
|
Surplus margin
Surplus as a share of revenue
|
0.9% | 3.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $2.2M | $2.2M | $1.7M | 92.0% | 3 |
| 2023 | $1.9M | $1.4M | $1.7M | 81.7% | 3 |
| 2022 | $2.5M | $1.4M | $1.1M | 88.9% | 3 |
| 2021 | $665K | $937K | N/A | — | 3 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.